What 'focal chondral defect' means in plain language

Receiving an MRI report with the words 'focal chondral defect' can feel alarming — but the language is more precise, and more hopeful, than it sounds.

Articular cartilage is the smooth, load-bearing surface that lines the ends of the bones inside your knee. Under normal conditions it absorbs impact and allows the joint to glide freely. Unlike most tissues, cartilage contains no blood vessels and no nerve fibres. That combination has two important consequences: first, damage cannot trigger the same repair cascade that heals a cut or a fracture; second, cartilage can be damaged without producing immediate pain, which is why some defects are discovered incidentally on scans ordered for an unrelated reason.

The word focal is the clinically significant part of the phrase. It means the damage is localised — a discrete area within a joint whose surrounding cartilage may be largely intact. That is meaningfully different from widespread osteoarthritis, in which cartilage loss is diffuse across one or more compartments. A focal defect is, in principle, a contained and potentially treatable lesion.

An MRI finding of this kind does not automatically lead to surgery, nor does it confirm that the defect is the source of your symptoms. Some focal defects are present in people with no knee pain at all; conversely, some people with significant symptoms have MRI appearances that do not fully reflect what is happening at the joint surface. What determines the next step is not the finding in isolation, but a combination of factors: the defect's depth, its size, its location within the joint, and how it maps onto your clinical picture.

Those factors — and how they are graded — are what the rest of this article works through.

How MRI grades cartilage damage

Two grading scales appear in cartilage MRI reports, and radiologists may use either — or both.

The Outerbridge scale (Grades I–IV) was first developed for direct arthroscopic inspection but has since been adapted for MRI using fat-saturated proton-density sequences, which are now the standard imaging protocol for cartilage assessment:

• Grade I — surface softening or swelling; the cartilage surface is intact but signal change indicates early structural disruption.
• Grade II — partial-thickness fissuring, with the affected area measuring less than 1.5 cm across.
• Grade III — deep fissures that reach toward the underlying bone, spanning more than 1.5 cm.
• Grade IV — full-thickness loss with bare subchondral bone exposed.

The ICRS scale (Grades 0–4) follows the same structural continuum but places the critical threshold at 50% of cartilage depth: Grade 2 means less than half the thickness is lost; Grade 3 means more than half, with subgrades A–D depending on how close the damage extends toward the calcified base layer. Grade 4 again represents complete thickness loss.

Both systems describe the same progression from surface roughening through partial thinning to full-thickness loss — the terminology differs, not the underlying anatomy.

How accurate is MRI grading?

Scanner quality influences what the images can resolve. A 3-Tesla MRI provides more reliable lesion localisation than a standard 1.5-Tesla scanner, and is worth confirming before your scan if cartilage detail is the primary question.

Even at 3T, MRI grading is a strong planning tool rather than a definitive verdict. Studies comparing MRI-based assessments with direct arthroscopic inspection have found sensitivity of around 70% — meaning a meaningful proportion of lesions are graded differently when viewed directly. That figure is why a reported grade always needs to be read alongside clinical examination and symptom history, not in isolation. Importantly, a higher grade does not by itself determine treatment; size, location, and how the defect maps onto your symptoms all carry equal weight.

Why your symptoms may not match your MRI grade

Grade numbers can create a misleading sense of certainty. The understandable assumption is that a higher grade means worse pain, and that how much something hurts indicates how serious the defect is. The evidence does not support this.

A 2026 cross-sectional study of 57 patients with MRI-confirmed focal chondral lesions found that WOMAC pain and function scores were broadly comparable between those graded ICRS 3 and those graded ICRS 4. The patients with the most severe structural damage reported no significantly greater symptoms than those a grade below them. Because cartilage carries no nerve fibres of its own — as noted above — pain arises from surrounding structures such as the synovium, the subchondral bone, and the meniscus. Those structures do not map neatly onto cartilage depth, which is why the two do not track together.

The practical implication runs in both directions. A person with Grade 4 disease may report modest pain; someone with Grade 3 changes may be significantly limited. Neither pattern is unusual, and neither reliably signals structural severity.

This is why MRI is indispensable at the decision stage rather than optional. An assessment based on symptoms and examination alone risks underestimating how far damage has progressed. Equally, a cartilage finding on a scan taken for another reason — in someone who has no knee pain — is not automatically a call to action. Imaging is one input into a clinical picture, not a verdict on its own.

What else the MRI reveals beyond the cartilage grade

Cartilage grade is only part of what a well-protocolled MRI reveals. The same scan shows the menisci, cruciate and collateral ligaments, synovial lining, and — critically — the subchondral bone beneath the defect. Bone marrow oedema, cysts, or sclerosis at the subchondral level can indicate abnormal load transfer through the joint, a factor that any repair strategy will need to account for, regardless of cartilage grade.

Co-existing meniscal damage is particularly common at higher grades. In the 2026 multimodal study, MRI identified a meniscal tear in 86% of patients with ICRS Grade 4 lesions, compared with 30% of those at Grade 3. That near-threefold difference matters clinically: it partly explains why McMurray's test was the only examination manoeuvre to vary significantly between grades — it was picking up the meniscal component, not cartilage depth itself. A treatment plan designed purely around the cartilage number would miss this entirely.

This is why a specialist should review the full MRI image sequences rather than relying solely on the radiologist's summary letter. A report may accurately describe both findings, but determining how they interact — and how that combination should shape management — requires a clinician working through the complete scan, not a one-line conclusion.

The treatment pathway your MRI grade points to

Knowing your grade matters most when it translates into a clear pathway. The logic that follows is a straightforward escalation ladder: every patient starts at the same point, and movement along it depends on lesion depth, lesion size, and whether earlier steps provide adequate relief.

Conservative management — the universal first step

Regardless of grade, the starting point is identical: physiotherapy targeting quadriceps strength and load management, weight optimisation where relevant, and — for symptomatic lesions — intra-articular injections. The injection options range from corticosteroids for inflammatory flares and hyaluronic acid for viscosupplementation, to platelet-rich plasma (PRP) and injectable collagen scaffolds such as ChondroFiller, which can be placed as an ultrasound-guided outpatient procedure to support matrix-induced chondrogenesis. For many Grade 1 and Grade 2 lesions, this stage achieves durable symptom control and surgical escalation is never required.

The two thresholds that determine surgical escalation

When conservative management does not provide sufficient relief, two variables govern the next decision: depth (partial- versus full-thickness) and size (below or above roughly 2–3 cm²), interpreted alongside the patient's age and activity demands.

Small to moderate full-thickness lesions (below approximately 3 cm²). Arthroscopic debridement addresses mechanical symptoms from unstable, fraying cartilage edges. For patients with moderate activity demands, microfracture — creating small channels in the exposed subchondral bone to draw marrow cells into the defect — is the standard first surgical step, producing a fibrocartilage fill. Osteochondral autograft transfer (mosaicplasty or OATS), which transplants intact cartilage plugs from a low-load donor site, has demonstrated superior long-term clinical scores compared with microfracture for similar-sized defects.

Larger defects (≥3 cm²). For younger, more active patients, matrix-associated autologous chondrocyte implantation (MACI) is the evidence-backed choice at this scale: the SUMMIT trial showed significantly better KOOS pain and function scores at both two and five years compared with microfracture.

Full-thickness cartilage damage carries a real risk of progressive joint deterioration. Because cartilage has no intrinsic healing capacity, higher-grade lesions tend to worsen over time and can eventually drive compartmental osteoarthritis requiring joint replacement. Exact individual progression rates are not well characterised in the current literature, which is why a specialist review — rather than watchful waiting — is the appropriate response to a significant MRI finding.

When to see a specialist and what to expect

Several clear signals suggest the time for self-management alone has passed: pain or functional limitation persisting beyond six to eight weeks of physiotherapy, an MRI returning a Grade 3 or 4 finding, or recurring episodes of locking, swelling, or giving-way that are not settling.

Specialist assessment at this stage is an information-gathering step, not a commitment to surgery. It covers a structured clinical history, a functional examination, and review of the full MRI sequences — not just the radiologist's summary letter — so that grade, lesion size, location, concomitant pathology, age, activity demand, and symptom duration can be read as a single integrated picture rather than isolated data points.

For patients in London and the commuter belt, that assessment is available at the London Cartilage Clinic on Harley Street, where the full treatment spectrum — including the ChondroFiller outpatient injection pathway, delivered by Professor Paul Y. F. Lee — is accessible. Enquiries can be made at londoncartilage.com.

Getting an accurate picture early rarely accelerates a patient toward surgery; more often, it confirms that a conservative or injection-based approach is appropriate at their current stage — and gives that route the best chance of working.

1. [1] Hyaline Cartilage — Wikipedia. https://en.wikipedia.org/?curid=1130627 https://en.wikipedia.org/?curid=1130627
2. [2] Articular Cartilage Repair — Wikipedia. https://en.wikipedia.org/?curid=19042351 https://en.wikipedia.org/?curid=19042351
3. [3] Autologous minced cartilage repair for chondral and osteochondral lesions: minimum five-year follow-up. (2023). https://doi.org/10.1007/s00167-023-07546-1 https://doi.org/10.1007/s00167-023-07546-1